84 results
Page 3 of 5
8-K
fxs5s59jrkg9j pe7
1 Jun 21
Submission of Matters to a Vote of Security Holders
4:02pm
S-3ASR
kfaqcyzhmtmid9 3xv2
3 May 21
Automatic shelf registration
4:33pm
DEFA14A
jd71v mt4dk7quy
19 Apr 21
Additional proxy soliciting materials
4:17pm
DEF 14A
p39lkts2v5q
19 Apr 21
Definitive proxy
4:15pm
10-K
u9ffnjwf
25 Mar 21
Annual report
8:23am
10-K
EX-31.2
uuug0zyxbybahf mu
25 Mar 21
Annual report
8:23am
10-K
EX-31.1
i7icn03
25 Mar 21
Annual report
8:23am
8-K
mknwnd
17 Dec 20
Keros Therapeutics Appoints Mary Ann Gray, Ph.D., to its Board of Directors
8:03am
424B4
yji3zu5 54echmc
13 Nov 20
Prospectus supplement with pricing info
4:02pm
8-K
EX-99.1
v18prdcjqm nz5i64
10 Nov 20
Other Events
5:14pm